Skip to main content
ADUS logo

ADUS · Addus HomeCare Corp

Track ADUS — free
$120.02 +1.89 (+1.60%) At close · Aug 19
Market Cap
$2.21B
Shares
18.67M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$120.02 Open$119.44 Day$119.02–120.53 52W close$88.49–122.75 Avg vol 30d229K Short int1.2M · 6.5% float · 5.1d Short vol64% Last earningsAug 4, 2026 DataJan 2020–Aug 2026 Filing10-Q · Aug 4

Up next

Next earnings call
Nov 3, 2026 Est · unconfirmed · in 11 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed Aug 4, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Strong Buy
      SellHoldBuy
      Technical Buy Momentum Very Strong Sentiment Very Bullish Fundamentals Strong Quant / Vol Moderate
      Market backdrop VIX 14.9 · calm Equity put/call 0.52
      Technical
      price trend
      Buy
      50 / 200-day cross Golden cross
      Price vs 200-day avg +14%
      above
      Price vs 50-day avg +11%
      above
      RSI (14) 63
      neutral
      MACD trend Negative
      52-week position 92%
      near high
      Momentum
      relative strength
      Very Strong
      1-month return +8%
      trailing
      6-month return +15%
      trailing
      YTD return +12%
      this year
      Relative strength +5%
      vs S&P · 6-mo
      Sentiment
      smart money
      Very Bullish
      Trend (MA cross) Golden cross
      50d $108 › 200d $105 — 50d above 200d
      Institutional flow Accumulating
      +1% holders QoQ · +44 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      6.46% of float · ▼ -3.8% MoM · 5.1 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      302 holders — near 3-yr high, broad support
      Squeeze score 71
      high risk · 0–100
      Fundamentals
      Strong
      Revenue growth +23%
      Y/Y
      Gross margin 32%
      contracting
      EPS growth +23%
      Y/Y
      Free cash flow $103.8M
      Valuation P/E 20.7
      in line
      Balance sheet $23.0M
      net debt
      Quant / Vol
      risk profile
      Moderate
      Volatility 30%
      annualized · 1-yr
      Max drawdown −28%
      past year
      ATR 2.8%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Prior guidance period ended · from the Earnings Call filed Mar 31, 2024
      Adjusted EBITDA margin percentage · full year 2024 at least 11%
      Cash flow as a percentage of unadjusted EBITDA · the full year 80%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Buy
      1 · 1 · 4
      50 / 200-day cross
      Golden cross Bullish
      Price vs 200-day avg
      +14% Bullish
      Price vs 50-day avg
      +11% Bullish
      RSI (14)
      63 Neutral
      MACD trend
      Negative Bearish
      52-week position
      92% Bullish
      Market signals — smart money & positioning
      Bullish · 4 of 6
      Trend (MA cross) Golden cross
      50d $108 › 200d $105 — 50d above 200d
      Institutional flow Accumulating
      +1% holders QoQ · +44 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      6.46% of float · ▼ -3.8% MoM · 5.1 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      302 holders — near 3-yr high, broad support
      Price context
      position in its 52-week range
      Range low $88 Now $120 · 92% Range high $123
      vs 200-day avg +14% vs 50-day avg +11% 50-day above 200-day golden cross

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Average billable hours per census per month 72.1 Six Months Ended June 30, 2026
      Home Health - New Admissions 9,710 Six Months Ended June 30, 2026
      Home Health - Recertifications 5,308 Six Months Ended June 30, 2026
      Home Health - Total Volume 15,018 Six Months Ended June 30, 2026
      Home Health - Visits 169,408 Six Months Ended June 30, 2026
      Hospice - Admissions 6,664 Six Months Ended June 30, 2026
      Hospice - Average daily census 3,899 Six Months Ended June 30, 2026
      Hospice - Average discharge length of stay 105.5 Six Months Ended June 30, 2026
      Hospice - Organic growth - Average daily census 7.6% Six Months Ended June 30, 2026
      Hospice - Patient days 703,051 Six Months Ended June 30, 2026
      Hospice - Revenue per patient day $191.03 Six Months Ended June 30, 2026
      Hospice organic revenue growth 11.1% the second quarter of 2026
      Locations 264 as of August 3, 2026
      Patients and consumers served 62,500 as of August 3, 2026
      Revenues per billable hour $26.36 Six Months Ended June 30, 2026
      States served 24 as of August 3, 2026
      Revolving credit facility availability $547.8M as of March 31, 2026
      Cash flow from operations $111.5M FY2025

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Medical Care Facilities — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      ADUS
      Addus HomeCare Corp
      this stock
      $2.21B +11.8% +23.2% 20.7 6.5%
      HCA
      HCA Healthcare, Inc.
      $90.30B -11.8% +7.1% 14.0 2.7%
      FSNUY
      Fresenius SE & Co. KGaA
      $30.84B -4.5% 0.0%
      THC
      Tenet Healthcare Corp
      $21.76B +36.0% +0.9% 10.4 4.0%
      FMS
      Fresenius Medical Care AG
      $12.69B -1.1% +5.9% 0.5%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      302
      % held
      104.0%
      Net QoQ
      +153.8K sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      328
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      1.2M
      Days to cover
      5.1d
      Change
      -47.4K sh
      View
      Short Volume
      Short vol %
      64%
      As of
      Aug 19, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      893
      Value
      $104.2K
      As of
      Jul 31, 2026
      View
      Off-Exchange
      Off-exchange %
      39.9%
      Week of
      Jul 13, 2026
      Off-exch Lit
      View
      Smart Money
      Congressional Trades Sell
      Member
      Donna Shalala
      Amount
      $1.0K–$15.0K
      Traded
      Jun 24, 2019
      View
      Financials
      Financials
      Revenue (FY)
      $1.4B
      Net income (FY)
      $95.9M
      EPS diluted
      $5.22
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 13, 2026
      This year
      10
      View
      Proposed Sales
      Value
      $1.0M
      Shares
      8.8K
      Filed
      Dec 5, 2025
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 4, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      ADUS +1.7% +7.7% +15.4% +3.9% +11.8%
      SPY -0.4% +2.6% +10.7% +2.7% +12.5%
      vs SPY +2.1% +5.2% +4.7% +1.2% -0.8%
      Key facts CIK 1468328 CUSIP 006739106 13F (30d) 279 filings 275 filers Visit website Investor relations